rosoxacin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
antibacterials, nalidixic acid derivatives 83 40034-42-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • acrosoxacin
  • eradacil
  • rosoxacin
  • eradacin
  • Molecular weight: 294.31
  • Formula: C17H14N2O3
  • CLOGP: 2.17
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 1
  • TPSA: 70.50
  • ALOGS: -3.46
  • ROTB: 3

Drug dosage:

DoseUnitRoute
0.30 g O

ADMET properties:

PropertyValueReference
BA (Bioavailability) 66 %

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR1B,ACVR2A,ACVR2B,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK5,CDK9,CLK4,DDR1,DYRK1A,DYRK1B,EGFR,EIF2AK3,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,IRAK1,ITK,JAK1,KIT,MAP3K10,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAPK7,MAPK9,MARK4,MKNK2,MTOR,PDK1,PDK2,PDK4,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM2,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TNIK,TTK,ULK1,ULK2 60
kinase-selectivity-class ACVR2A,ACVR2B,AXL,BRAF,CAMK2B,CAMK2D,CDK9,DYRK1A,DYRK1B,EIF2AK3,ERBB2,GRK2,MAP2K6,MAPK7,PRKDC,SIK2,STK33,TGFBR1 18
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC J01MB01 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
QUINOLONE ANTIBACTERIALS
Other quinolones
MeSH PA D000890 Anti-Infective Agents
CHEBI has role CHEBI:33282 antibacterial agent
CHEBI has role CHEBI:35441 antiinfective agent
CHEBI has role CHEBI:36047 antibacterial drug

Related Drugs by ATC class:

J01MB Other quinolones 7 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 6.11 acidic
pKa2 5.45 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D02305 KEGG_DRUG
151711 RXNORM
CHEBI:131715 CHEBI
CHEMBL291157 ChEMBL_ID
C021083 MESH_SUPPLEMENTAL_RECORD_UI
12474 IUPHAR_LIGAND_ID
3903 INN_ID
DB00817 DRUGBANK_ID
3Y1OT3J4NW UNII
C0073591 UMLSCUI
287180 PUBCHEM_CID
004035 NDDF
387556005 SNOMEDCT_US
96093003 SNOMEDCT_US

Pharmaceutical products:

None